Skip to main content

Table 1 Summary of clinical and pathologic characteristics of the 50 primary melanoma

From: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Breslow thickness (mm), range, SD

4,71 (0,25-24,00)(±3,98)

 ≤1,00

4 (8)

 1,00-2,00

7 (14)

 2,01–4,00

18 (36)

 > 4,00

21 (42)

Histological subtype

 SSM

20 (40)

 NM

20 (40)

 ALM

1 (2)

 LMM

1 (2)

 Unclassified

8 (16)

Anatomic distribution

 Trunk

21 (42)

 Head and neck

9 (18)

 Extremities

20 (40)

Stage at diagnosis

 IB

4 (8)

 IIA

10 (20)

 IIB

12 (24)

 IIC

12 (24)

 IIIA

3 (6)

 IIIB

5 (10)

 IV

4 (8)

Specific histopathological restrictions

 ulceration

24 (48)

 regression

4 (8)

 solar elastosis

8 (16)

 association with a coexistent naevus

4 (8)

Gender

 Male

34 (68)

 Female

16 (32)

Age at surgery (years), range, SD

53 (22–81) (±16,14)

  < 50

20 (40)

  ≥ 50

30 (60)

DNA concentration (ng/ul), SD

134,61 (±115,54)

OS (month), range, SD

45 (1–144) (±35,64)

Tumor content (%), SD

79,1 (±20,14)

  1. Abbreviations: ALM acrolentiginous melanoma, LMM lentigo maligna melanoma, NM nodular melanoma, OS overall survival, SD standard deviation, SSM superficial spreading melanoma